| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |